Report: Novartis and Roche are about to reach a drug pricing agreement in the United States, easing trade tensions in Switzerland

According to informed sources, the White House is expected to announce a drug pricing agreement with pharmaceutical giants Novartis and Roche as early as Friday, a move that will further ease trade tensions with Switzerland. Other pharmaceutical companies may also appear on the announcement list; in recent months, companies such as Pfizer and AstraZeneca have signed similar agreements. As part of efforts to lower drug prices in the United States, these companies have agreed to cut costs in exchange for tariff exemptions and potential regulatory relief. (Bloomberg)